Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03983993
Title Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer (NIPAVect)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Emory University

colorectal cancer


Niraparib + Panitumumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST